Fortitude Family Office’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.2K Sell
128
-10
-7% -$4.8K 0.01% 243
2026
Q1
$67.8K Sell
138
-1,322
-91% -$717K 0.02% 196
2025
Q4
$846K Buy
1,460
+53
+4% +$30K 0.2% 82
2025
Q3
$682K Buy
1,407
+18
+1% +$8.38K 0.18% 83
2025
Q2
$563K Sell
1,389
-34
-2% -$14.2K 0.18% 73
2025
Q1
$708K Sell
1,423
-16
-1% -$8.67K 0.25% 54
2024
Q4
$749K Buy
1,439
+12
+0.8% +$6.6K 0.27% 57
2024
Q3
$883K Buy
1,427
+35
+3% +$20.7K 0.35% 41
2024
Q2
$770K Hold
1,392
0.44% 37
2024
Q1
$809K Hold
1,392
0.54% 28
2023
Q4
$739K Buy
+1,392
New +$674K 0.55% 29

Other funds holding TMO

Fortitude Family Office's TMO Position: Q2 2026 in Review

Fortitude Family Office reduced its Thermo Fisher Scientific (TMO) stake by 7.2% in Q2 2026, selling an estimated $4.8K and leaving 128 shares worth $64.2K. The position accounts for 0.01% of the portfolio, ranked #243.

Fortitude Family Office first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $883K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Fortitude Family Office held 128 shares of Thermo Fisher Scientific worth $64.2K as of Q2 2026.
  • Fortitude Family Office sold 10 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.8K.
  • Thermo Fisher Scientific made up 0.01% of Fortitude Family Office's portfolio in Q2 2026, its #243 holding.
  • Fortitude Family Office first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Fortitude Family Office's Thermo Fisher Scientific position peaked at $883K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.